Share-based Payment Arrangement, Expense of TELA Bio, Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
TELA Bio, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • TELA Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $955,000, a 12% decline year-over-year.
  • TELA Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $4,073,000, a 9.8% decline year-over-year.
  • TELA Bio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $4,362,000, a 13% decline from 2023.
  • TELA Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5,032,000, a 26% increase from 2022.
  • TELA Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3,989,000, a 9% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

TELA Bio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,073,000 $955,000 -$126,000 -12% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $4,199,000 $985,000 -$105,000 -9.6% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $4,304,000 $1,044,000 -$58,000 -5.3% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $4,362,000 $1,089,000 -$152,000 -12% 01 Oct 2024 31 Dec 2024 10-K 21 Mar 2025 2024 FY
Q3 2024 $4,514,000 $1,081,000 -$288,000 -21% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $4,802,000 $1,090,000 -$204,000 -16% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $5,006,000 $1,102,000 -$26,000 -2.3% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $5,032,000 $1,241,000 +$202,000 +19% 01 Oct 2023 31 Dec 2023 10-K 21 Mar 2025 2024 FY
Q3 2023 $4,830,000 $1,369,000 +$342,000 +33% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 $4,488,000 $1,294,000 +$272,000 +27% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $4,216,000 $1,128,000 +$227,000 +25% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 $3,989,000 $1,039,000 +$217,000 +26% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2025 2024 FY
Q3 2022 $3,772,000 $1,027,000 +$294,000 +40% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $3,478,000 $1,022,000 -$390,000 -28% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $3,868,000 $901,000 +$207,000 +30% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $3,661,000 $822,000 +$250,000 +44% 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2024 2023 FY
Q3 2021 $3,411,000 $733,000 +$190,000 +35% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $3,221,000 $1,412,000 +$918,000 +186% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $2,303,000 $694,000 +$245,000 +55% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022 2022 Q1
Q4 2020 $2,058,000 $572,000 +$298,000 +109% 01 Oct 2020 31 Dec 2020 10-K 23 Mar 2023 2022 FY
Q3 2020 $1,760,000 $543,000 +$479,000 +748% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $1,281,000 $494,000 +$435,000 +737% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $846,000 $449,000 +$389,000 +648% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q4 2019 $457,000 $274,000 01 Oct 2019 31 Dec 2019 10-K 23 Mar 2022 2021 FY
Q3 2019 $64,000 +$3,000 +4.9% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $59,000 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $60,000 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q3 2018 $61,000 01 Jul 2018 30 Sep 2018 10-Q 18 Dec 2019 2019 Q3

TELA Bio, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $4,362,000 -$670,000 -13% 01 Jan 2024 31 Dec 2024 10-K 21 Mar 2025 2024 FY
2023 $5,032,000 +$1,043,000 +26% 01 Jan 2023 31 Dec 2023 10-K 21 Mar 2025 2024 FY
2022 $3,989,000 +$328,000 +9% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2025 2024 FY
2021 $3,661,000 +$1,603,000 +78% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2024 2023 FY
2020 $2,058,000 +$1,601,000 +350% 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2023 2022 FY
2019 $457,000 +$241,000 +112% 01 Jan 2019 31 Dec 2019 10-K 23 Mar 2022 2021 FY
2018 $216,000 +$19,000 +9.6% 01 Jan 2018 31 Dec 2018 10-K 25 Mar 2021 2020 FY
2017 $197,000 01 Jan 2017 31 Dec 2017 10-K 30 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.